Dr. Simpson, a neurologist, occasionally participates on an advisory board for Lightning Pharmaceuticals. Dr. Simpson has also just become a member of a national committee that makes recommendations for clinical guidelines and formulary decisions. Is Dr. Simpson required to disclose her relationship with Lightning Pharmaceuticals to the national committee she is a member of?

Dr. Simpson, a neurologist, occasionally participates on an advisory board for Lightning Pharmaceuticals. Dr. Simpson has also just become a member of a national committee that makes recommendations for clinical guidelines and formulary decisions. Is Dr. Simpson required to disclose her relationship with Lightning Pharmaceuticals to the national committee she is a member of?

• A. No, not required
• B. Yes, it would be unethical and potentially a conflict of interest if she does not disclose the relationship
• C. Only if the committee asks for disclosure
• D. It depends on the policy of the company

Answer: (B)

The essential idea is that conflicts of interest must be disclosed whenever a clinician participates in guideline development or formulary decisions. A clinician serving on an advisory board for an industry sponsor has a financial relationship that could influence judgments, even if the topic seems unrelated. To keep the process transparent and trustworthy, professionals are expected to disclose any such relationships to the committee so that potential bias can be identified and appropriately managed. Not disclosing would undermine the integrity of the recommendations and could raise ethical concerns. Disclosures are typically required by the committee’s policies and by professional guidelines, and they may lead to recusal from certain topics or other management steps. The obligation does not hinge on the company’s policy or on whether the committee explicitly asks for disclosure; it flows from ethical standards and the committee’s governance requirements.

The essential idea is that conflicts of interest must be disclosed whenever a clinician participates in guideline development or formulary decisions. A clinician serving on an advisory board for an industry sponsor has a financial relationship that could influence judgments, even if the topic seems unrelated. To keep the process transparent and trustworthy, professionals are expected to disclose any such relationships to the committee so that potential bias can be identified and appropriately managed. Not disclosing would undermine the integrity of the recommendations and could raise ethical concerns.

Disclosures are typically required by the committee’s policies and by professional guidelines, and they may lead to recusal from certain topics or other management steps. The obligation does not hinge on the company’s policy or on whether the committee explicitly asks for disclosure; it flows from ethical standards and the committee’s governance requirements.